Assessment of the SurroundScope in Urologic Surgical Procedures

NCT ID: NCT05106218

Last Updated: 2022-02-09

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

100 participants

Study Classification

INTERVENTIONAL

Study Start Date

2022-03-31

Study Completion Date

2022-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The aim of this study is to evaluate standard urological surgeries using the 270Surgical system vs same procedures using the standard scope

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The tremendous popularity of the laparoscopic surgeries is balanced with its tradeoffs - the needs for an excellent intracavitary visualization along with a surgeon skill set capable of performing these, often more technically challenging procedures. Image quality has improved, but there are still various restrictions to images captured by the lens at the tip of a long tubular laparoscope. 270Surgical developed a 270 degree angle scope to overcome these unmet needs and improve the image quantity and extent during laparoscopy. The study will compare the use of the 270Surgical system (The "SurroundScope") to standard laparoscope during partial nephrectomy and nephrectomy urological surgeries;

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Partial Nephrectomy Nephrectomy Laparoscopy

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

For laparoscopic camera system to be used in urological surgeries, the SurroundScope, 270-degree angle videoscope (270Surgical, Israel) is used. This will be compared to the standard laparoscopic system use.

The study will evaluate standard urological surgeries using the 270Surgical system vs same procedures using the standard scope. The procedure will be performed according to the institution's standard of care, using the SurroundScope or the standard scope for visualization. Each surgery will be captured on video.
Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Participants
Patients are not aware of the laparoscopic system that will be used during the operation.

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

SurroundScope

For laparoscopic camera system, the SurroundScope, 270-degree angle videoscope (270Surgical, Israel) is used

Group Type EXPERIMENTAL

SurroundScope

Intervention Type DEVICE

The procedure will be performed according to the institution's standard of care, using the SurroundScope for visualization.

Standard laparoscope

For laparoscopic camera system, the Standard laparoscope that is in a standard use at the medical center is used

Group Type ACTIVE_COMPARATOR

Standard Laparoscope

Intervention Type DEVICE

The procedure will be performed according to the institution's standard of care, using the Standard laparoscope for visualization.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

SurroundScope

The procedure will be performed according to the institution's standard of care, using the SurroundScope for visualization.

Intervention Type DEVICE

Standard Laparoscope

The procedure will be performed according to the institution's standard of care, using the Standard laparoscope for visualization.

Intervention Type DEVICE

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

270System

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Age greater than or equal to 18
* Capable of giving informed consent.
* Scheduled for laparoscopic urologic surgery: Partial nephrectomy, Nephrectomy

Exclusion Criteria

* Unfit for surgery: concomitant disorders incompatible with the study or surgery (at the discretion of the investigator)
* Patients with contraindications to undergo laparoscopic surgery.
* Patients with American Society of Anesthesiology (ASA) class\* \>3
* Advanced cirrhosis with failure of hepatic function
* Patients who have participated in another interventional clinical study in the last month.
* Pregnancy
* Unable to consent (due to cultural, language or neurological barriers)
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

270Surgical

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Andrew Nado, MD

Role: PRINCIPAL_INVESTIGATOR

Rabin Medical Center, 39 Jabotinski St., Petah Tikva 49100

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Rabin Medical Center

Petah Tikva, , Israel

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Israel

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Andrew Nado, MD

Role: CONTACT

+972 (0)547228500

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Andrew Nado, MD

Role: primary

+972 (0)547228500

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

CL 466

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.